Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Sales | 1,299,744 | 1,253,793 | 1,281,256 | 1,161,792 | 1,241,620 |
| Cost of Goods | 152,566 | 141,360 | 130,025 | 146,498 | 160,854 |
| Gross Profit | 1,147,178 | 1,112,433 | 1,151,231 | 1,015,294 | 1,080,766 |
| Operating Expenses | 931,991 | 906,188 | 806,866 | 797,050 | 824,543 |
| Operating Income | 215,753 | 206,605 | 344,390 | 218,742 | 257,077 |
| Interest Expense | 0 | 0 | 0 | 186 | 170 |
| Other Income | 34,300 | 8,674 | 10,122 | 21,159 | 25,400 |
| Pre-tax Income | 250,053 | 215,279 | 354,512 | 239,715 | 282,307 |
| Income Tax | 48,409 | 31,381 | 36,689 | 8,096 | 26,802 |
| Net Income Continuous | 201,644 | 183,898 | 317,823 | 231,619 | 255,505 |
| Minority Interests | 988 | -189 | 7,596 | 256 | 354 |
| Net Income | $200,656 | $184,087 | $310,227 | $231,363 | $255,151 |
| EPS Basic Total Ops | 2.10 | 1.84 | 3.07 | 2.30 | 2.51 |
| EPS Basic Continuous Ops | 2.11 | 1.84 | 3.14 | 2.30 | 2.51 |
| EPS Diluted Total Ops | 2.05 | 1.81 | 2.97 | 2.25 | 2.44 |
| EPS Diluted Continuous Ops | 2.06 | 1.80 | 3.04 | 2.25 | 2.44 |
| EPS Diluted Before Non-Recurring Items | 2.60 | 2.24 | 3.06 | 2.30 | 2.44 |
| EBITDA(a) | $310,407 | $311,654 | $458,520 | $331,426 | $342,558 |